Mary Lee, MD

Association of peripubertal blood lead levels with reproductive hormones and semen parameters in a longitudinal cohort of Russian men; Human Reproduction; (2022).

Urinary phthalate metabolite concentrations during four windows spanning puberty (prepuberty through sexual maturity) and association with semen quality among young Russian men; International Journal of Hygiene and Environmental Health; (2022).

Peripubertal serum levels of dioxins, furans and PCBs in a cohort of Russian boys: can empirical grouping methods yield meaningful exposure variables?; Chemosphere; (2021).

Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics; Clinical Pharmacology and Therapeutics; (2021).

Perspectives on molecular diagnostic testing for the covid-19 pandemic in delaware; Delaware Journal of Public Health; (2020).

Comparison of bioimpedance body composition in young adults in the Russian Children's Study; Clinical Nutrition ESPEN; (2020).

Associations of peri-pubertal serum dioxins and polychlorinated biphenyls with growth and body composition among Russian boys in a longitudinal cohort; International Journal of Hygiene and Environmental Health; (2020).

Peripubertal serum concentrations of organochlorine pesticides and semen parameters in Russian young men.; Environment international; (2020).

Protein arginine methyltransferase 5 promotes metastasis via enhancing EGFR transcription and modulating AKT1 activation by methylation; bioRxiv; (2020).

Blood lead levels and timing of male sexual maturity: A longitudinal study of Russian boys; Environment International; (2019).

Peripubertal serum dioxin concentrations and subsequent sperm methylome profiles of young Russian adults; Reproductive Toxicology; (2018).

Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis; Journal of Biological Chemistry; (2018).

Expression of inflammatory markers in women with perinatal depressive symptoms; Archives of Women's Mental Health; (2018).

Endocrine disrupters and pubertal timing; Current Opinion in Endocrinology, Diabetes and Obesity; (2018).

The association of peripubertal serum concentrations of organochlorine chemicals and blood lead with growth and pubertal development in a longitudinal cohort of boys: A review of published results from the Russian Children's Study; Reviews on Environmental Health; (2017).

Peripubertal blood lead levels and growth among Russian boys; Environment International; (2017).

Intervention fidelity: Monitoring drift, providing feedback, and assessing the control condition; Nursing Research; (2017).

An Unusual Manifestation of Celiac Disease in an Adolescent with Down Syndrome and Graves Disease; Journal of Pediatric Gastroenterology and Nutrition; (2017).

A longitudinal study of Peripubertal serum organochlorine concentrations and semen parameters in young men: The Russian children's study; Environmental Health Perspectives; (2017).

Unresolved issues in the wake of newborn screening for congenital hypothyroidism; Journal of Pediatrics; (2016).

PETS-D (parents education through simulation-diabetes): Parents' qualitative results; Patient Education and Counseling; (2016).

Associations of peripubertal serum dioxin and polychlorinated biphenyl concentrations with pubertal timing among Russian boys; Environmental Health Perspectives; (2016).

A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in Overweight/Obese youth with type 1 diabetes; PLoS ONE; (2015).

PETS-D: Impact on Diabetes Management Outcomes; The Diabetes Educator; (2015).

Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes; Diabetes Technology and Therapeutics; (2015).

Understanding multifactorial influences on the continuum of maternal weight trajectories in pregnancy and early postpartum: Study protocol, and participant baseline characteristics; BMC Pregnancy and Childbirth; (2015).

Prepubertal serum concentrations of organochlorine pesticides and age at sexual maturity in Russian boys; Environmental Health Perspectives; (2015).

Prepubertal organochlorine pesticide concentrations and age of pubertal onset among Russian boys; Environment International; (2014).

Engaging Teens and Parents in Collaborative Practice: Perspectives on Diabetes Self-Management; The Diabetes Educator; (2014).

Association between chlorinated pesticides in the serum of prepubertal russian boys and longitudinal biomarkers of metabolic function; American Journal of Epidemiology; (2014).

Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children; Journal of Pediatric Endocrinology and Metabolism; (2013).

Predictors of serum chlorinated pesticide concentrations among prepubertal Russian boys; Environmental Health Perspectives; (2013).

Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes; Diabetes Technology and Therapeutics; (2013).

Male pubertal development: Are endocrine-disrupting compounds shifting the norms?; Journal of Endocrinology; (2013).

Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys; Environmental Health Perspectives; (2013).

Blood lead levels and serum insulin-like growth factor 1 concentrations in peripubertal boys; Environmental Health Perspectives; (2013).

Serum concentrations of organochlorine pesticides and growth among Russian boys; Environmental Health Perspectives; (2012).

Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus; Journal of Pediatric Endocrinology and Metabolism; (2012).

Farm residence and reproductive health among boys in rural South Africa; Environment International; (2012).

Development and Pilot Testing of a Parent Education Intervention for Type 1 Diabetes: Parent Education Through Simulation–Diabetes; The Diabetes Educator; (2012).

The influence of endocrine disruptors on male pubertal timing; Endocrine Disruptors and Puberty; (2012).

Müllerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation; Endocrinology; (2012).

Educating diabetes camp counselors with a human patient simulator: A pilot study; Journal for Specialists in Pediatric Nursing; (2012).

Endocrine-disrupting compounds and pubertal development: The effects of environmental compounds on the timing of puberty in humans; Handbook of Growth and Growth Monitoring in Health and Disease; (2012).

Mentoring fathers of children newly diagnosed with T1DM; MCN The American Journal of Maternal/Child Nursing; (2011).

Evidence of insulin-like growth factor binding protein-3 proteolysis during growth hormone stimulation testing; Journal of Pediatric Endocrinology and Metabolism; (2011).

Dioxin exposure and age of pubertal onset among Russian boys; Environmental Health Perspectives; (2011).

Dioxin and polychlorinated biphenyl concentrations in mother's serum and the timing of pubertal onset in sons; Epidemiology; (2011).

A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics; Journal of Pediatric Endocrinology and Metabolism; (2011).

Serum dioxins and polychlorinated biphenyls are associated with growth among Russian boys; Pediatrics; (2011).

Parent mentor perspectives on providing social support to empower parents; Diabetes Educator; (2011).

Temporal trends in serum concentrations of polychlorinated dioxins, furans, and PCBs among adult women living in Chapaevsk, Russia: A longitudinal study from 2000 to 2009; Environmental Health: A Global Access Science Source; (2011).

Social support to empower parents (STEP): An intervention for parents of young children newly diagnosed with type 1 diabetes; Diabetes Educator; (2010).

Predictors of serum dioxin, furan, and PCB concentrations among women from chapaevsk, Russia; Environmental Science and Technology; (2010).

Infant formula, autoimmune triggers, and type 1 diabetes; New England Journal of Medicine; (2010).

Blood lead levels and delayed onset of puberty in a longitudinal study of Russian boys; Pediatrics; (2010).

Androgen profiles during pubertal Leydig cell development in mice; Reproduction; (2010).

Pseudohypoparathyroidism type 1a and insulin resistance in a child; Nature Reviews Endocrinology; (2009).

Predictors of serum dioxins and PCBs among peripubertal Russian boys; Environmental Health Perspectives; (2009).

Do atypical antipsychotic agents trigger autoimmune diabetes?; Endocrinologist; (2009).

A single base pair mutation encoding a premature stop codon in the MIS type II receptor is responsible for canine persistent Müllerian duct syndrome; Journal of Andrology; (2009).

The influence of endocrine disruptors on pubertal timing; Current Opinion in Endocrinology, Diabetes and Obesity; (2009).

Association of blood lead levels with onset of puberty in Russian boys; Environmental Health Perspectives; (2008).

Evaluation of short and tall stature in children; American Family Physician; (2008).

Multifetal pregnancy may increase the risk for severe maternal and neonatal vitamin D deficiency; Endocrinologist; (2008).

Urinary prostate-specific antigen is a noninvasive indicator of sexual development in male children: Editorial commentary; Journal of Andrology; (2007).

Key factors in the regulation of fetal and postnatal leydig cell development; Journal of Cellular Physiology; (2007).

p19^Ink4d and p18^Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis; Molecular Reproduction and Development; (2007).

Idiopathic short stature; New England Journal of Medicine; (2006).

The author replies [13]; New England Journal of Medicine; (2006).

The 2006 Annual Meeting of the Lawson Wilkins Pediatric Endocrine Society (LWPES), April 29 - May 2, San Francisco; Pediatric Endocrinology Reviews; (2006).

Triploid mosaicism in a 45,X/69,XXY infant; American Journal of Medical Genetics; (2005).

Pubertal and adult leydig cell function in mullerian inhibiting substance-deficient mice; Endocrinology; (2005).

Predictors of serum dioxin levels among adolescent boys in Chapaevsk, Russia: A cross-sectional pilot study; Environmental Health: A Global Access Science Source; (2005).

Müllerian-Inhibiting Substance Inhibits Rat Leydig Cell Regeneration after Ethylene Dimethanesulphonate Ablation; Biology of Reproduction; (2004).

Hypothyroidism in Down Syndrome: Screening Guidelines and Testing Methodology [4]; American Journal of Medical Genetics; (2004).

Delayed Puberty; Pediatric Endocrinology; (2004).

Intersex Disorders; Pediatric Endocrinology; (2004).

The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization; Journal of Clinical Endocrinology and Metabolism; (2003).

Reproductive hormones in infant girls - A harbinger of adult reproductive function?; Journal of Clinical Endocrinology and Metabolism; (2003).

Physical growth and sexual maturation of boys in chapaevsk, Russia; Journal of Pediatric Endocrinology and Metabolism; (2003).

MIS/AMH in the assessment of cryptorchidism and intersex conditions; Molecular and Cellular Endocrinology; (2003).

Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?; New England Journal of Medicine; (2003).

Is luteinizing hormone-releasing hormone agonist justified in short adolescents? [3] (multiple letters); New England Journal of Medicine; (2003).

Transient hyperthyroidism in an adolescent with hydatidiform mole; Journal of Pediatrics; (2002).

Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism; Journal of Clinical Endocrinology and Metabolism; (2002).

Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus; Journal of Pediatrics; (2002).

Müllerian inhibiting substance inhibits testosterone synthesis in adult rats; Journal of Andrology; (2001).

Müllerian inhibiting substance: A nontraditional marker of gonadal function; Current Opinion in Endocrinology and Diabetes; (2001).

Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors; Gynecologic Oncology; (1999).

Clinical applications of Mullerian inhibiting substance in patients with gonadal disorders; Endocrinologist; (1999).

Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells; Endocrinology; (1999).

The infant with ambiguous genitalia.; Current therapy in endocrinology and metabolism; (1997).

Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood; Journal of Clinical Endocrinology and Metabolism; (1996).

Developmental Expression of a Candidate Müllerian Inhibiting Substance Type II Receptor; Endocrinology; (1996).

Ambiguous genitalia.; Current therapy in endocrinology and metabolism; (1994).

Type I glycogen storage disease: Nine years of management with cornstarch; European Journal of Pediatrics; (1993).

Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities; Journal of Pediatric Surgery; (1993).

Mullerian Inhibiting Substance is present in embryonic testes of dogs with Persistent Mullerian Duct Syndrome; Biology of Reproduction; (1993).

Isolation of the rat gene for Mullerian inhibiting substance; Genomics; (1992).

Clinical management of intersex abnormalities; Current Problems in Surgery; (1991).